The Wnt Signaling Pathway Effector TCF7L2 Mediates Olanzapine-Induced Weight Gain and Insulin Resistance
出版年份 2018 全文链接
标题
The Wnt Signaling Pathway Effector TCF7L2 Mediates Olanzapine-Induced Weight Gain and Insulin Resistance
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-04-16
DOI
10.3389/fphar.2018.00379
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Visceral Fat Dysfunctions in the Rat Social Isolation Model of Psychosis
- (2017) Stefania Schiavone et al. Frontiers in Pharmacology
- Wnt Signaling Genes in Adipose Tissue and Skeletal Muscle of Humans With Different Degrees of Insulin Sensitivity
- (2016) Monika Karczewska-Kupczewska et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Sex Differences in Body Mass Index and Obesity in Chinese Patients With Chronic Schizophrenia
- (2016) Qiongzhen Li et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Olanzapine-depot administration induces time-dependent changes in adipose tissue endocrine function in rats
- (2016) Katerina Horska et al. PSYCHONEUROENDOCRINOLOGY
- Acute Wnt pathway activation positively regulates leptin gene expression in mature adipocytes
- (2015) Zong-Lan Chen et al. CELLULAR SIGNALLING
- Liver-Specific Expression of Dominant-Negative Transcription Factor 7-Like 2 Causes Progressive Impairment in Glucose Homeostasis
- (2015) Wilfred Ip et al. DIABETES
- Antipsychotic-induced weight gain in first-episode psychosis patients: a meta-analysis of differential effects of antipsychotic medications
- (2015) Cenk Tek et al. Early Intervention in Psychiatry
- Effects of haloperidol and clozapine administration on oxidative stress in rat brain, liver and serum
- (2015) Ana C. Andreazza et al. NEUROSCIENCE LETTERS
- Evidence of non-pancreatic beta cell-dependent roles of Tcf7l2 in the regulation of glucose metabolism in mice
- (2014) Kathleen A. Bailey et al. HUMAN MOLECULAR GENETICS
- Phosphorylation of hypothalamic AMPK on serine485/491 related to sustained weight loss by alpha-lipoic acid in mice treated with olanzapine
- (2014) Hyunjeong Kim et al. PSYCHOPHARMACOLOGY
- A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics
- (2014) Marilena Gilca et al. PSYCHOPHARMACOLOGY
- Metformin for Weight Loss and Metabolic Control in Overweight Outpatients With Schizophrenia and Schizoaffective Disorder
- (2013) L. Fredrik Jarskog et al. AMERICAN JOURNAL OF PSYCHIATRY
- Meta-Analysis of Oxidative Stress in Schizophrenia
- (2013) Joshua Flatow et al. BIOLOGICAL PSYCHIATRY
- LRP6 Enhances Glucose Metabolism by Promoting TCF7L2-Dependent Insulin Receptor Expression and IGF Receptor Stabilization in Humans
- (2013) Rajvir Singh et al. Cell Metabolism
- An emerging role for Wnt and GSK3 signaling pathways in schizophrenia
- (2013) KK Singh CLINICAL GENETICS
- Antipsychotic-Induced Insulin Resistance and Postprandial Hormonal Dysregulation Independent of Weight Gain or Psychiatric Disease
- (2013) Karen L. Teff et al. DIABETES
- Course of weight gain and metabolic abnormalities in first treated episode of psychosis: the first year is a critical period for development of cardiovascular risk factors
- (2013) Rocio Pérez-Iglesias et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Effects of Adjunctive Metformin on Metabolic Traits in Nondiabetic Clozapine-Treated Patients With Schizophrenia and the Effect of Metformin Discontinuation on Body Weight
- (2013) Chun-Hsin Chen et al. JOURNAL OF CLINICAL PSYCHIATRY
- Chronic treatment with olanzapine increases adiposity by changing fuel substrate and causes desensitization of the acute metabolic side effects
- (2013) Elodie M. Girault et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- The Effects of Ziprasidone, Clozapine and Haloperidol on Lipid Peroxidation in Human Plasma (in vitro): Comparison
- (2013) Anna Dietrich-Muszalska et al. NEUROCHEMICAL RESEARCH
- Antidiabetic-drug combination treatment for glucose intolerance in adult female rats treated acutely with olanzapine
- (2013) Heidi N. Boyda et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Diabetes Risk Gene and Wnt Effector Tcf7l2/TCF4 Controls Hepatic Response to Perinatal and Adult Metabolic Demand
- (2012) Sylvia F. Boj et al. CELL
- Understanding the Elusive Mechanism of Action of TCF7L2 in Metabolism
- (2012) S. F. A. Grant DIABETES
- The Wnt Signaling Pathway Effector TCF7L2 Controls Gut and Brain Proglucagon Gene Expression and Glucose Homeostasis
- (2012) W. Shao et al. DIABETES
- Adipose Tissue TCF7L2 Splicing Is Regulated by Weight Loss and Associates With Glucose and Fatty Acid Metabolism
- (2012) D. Kaminska et al. DIABETES
- Reduction in Tcf7l2 Expression Decreases Diabetic Susceptibility in Mice
- (2012) Hyekyung Yang et al. International Journal of Biological Sciences
- Metabolic Effects of Paliperidone Extended Release Versus Oral Olanzapine in Patients With Schizophrenia
- (2012) Andreas Schreiner et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Association of the Type 2 Diabetes Mellitus Susceptibility Gene, TCF7L2, with Schizophrenia in an Arab-Israeli Family Sample
- (2012) Anna Alkelai et al. PLoS One
- Energy metabolism, leptin, and biochemical parameters are altered in rats subjected to the chronic administration of olanzapine
- (2012) Alexandra I. Zugno et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Is the Prevalence of Metabolic Syndrome and Metabolic Abnormalities Increased in Early Schizophrenia? A Comparative Meta-Analysis of First Episode, Untreated and Treated Patients
- (2012) A. J. Mitchell et al. SCHIZOPHRENIA BULLETIN
- Metformin for treatment of antipsychotic-induced weight gain: A randomized, placebo-controlled study
- (2012) Man Wang et al. SCHIZOPHRENIA RESEARCH
- At-Risk Variant in TCF7L2 for Type II Diabetes Increases Risk of Schizophrenia
- (2011) Thomas Hansen et al. BIOLOGICAL PSYCHIATRY
- Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice
- (2011) M. De Hert et al. EUROPEAN PSYCHIATRY
- Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism
- (2011) D. Savic et al. GENOME RESEARCH
- TCF7L2 splice variants have distinct effects on β-cell turnover and function
- (2011) Olivier Le Bacquer et al. HUMAN MOLECULAR GENETICS
- Insulin Resistance, Low Cardiorespiratory Fitness, and Increased Exercise Blood Pressure
- (2011) Maxime Huot et al. HYPERTENSION
- Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats
- (2011) Silje Skrede et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The effects of neuropsychiatric drugs on glycogen synthase kinase-3 signaling
- (2011) L.P. Sutton et al. NEUROSCIENCE
- Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders—A Systematic Review and Meta-Analysis
- (2011) Alex J. Mitchell et al. SCHIZOPHRENIA BULLETIN
- Metabolic syndrome with the atypical antipsychotics
- (2011) Pornpoj Pramyothin et al. Current Opinion in Endocrinology Diabetes and Obesity
- Comorbidity of metabolic syndrome, diabetes and schizophrenia: theoretical and practical considerations
- (2011) János Réthelyi et al. ORVOSI HETILAP
- The balance of TCF7L2 variants with differential activities in Wnt-signaling is regulated by lithium in a GSK3β-independent manner
- (2010) Ian Struewing et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Metformin Reduces Body Weight Gain and Improves Glucose Intolerance in High-Fat Diet-Fed C57BL/6J Mice
- (2010) Yukari Matsui et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Metformin for olanzapine-induced weight gain: a systematic review and meta-analysis
- (2010) Samir Kumar Praharaj et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Metformin for Atypical Antipsychotic-Induced Weight Gain and Glucose Metabolism Dysregulation
- (2010) Mehrul Hasnain et al. CNS DRUGS
- Cardiovascular aspects of antipsychotics
- (2010) Thomas J Raedler CURRENT OPINION IN PSYCHIATRY
- Clozapine Treatment Causes Oxidation of Proteins Involved in Energy Metabolism in Lymphoblastoid Cells: A Possible Mechanism for Antipsychotic- Induced Metabolic Alterations
- (2010) Muhammad R. Baig et al. Journal of Psychiatric Practice
- Atypical Antipsychotics Rapidly and Inappropriately Switch Peripheral Fuel Utilization to Lipids, Impairing Metabolic Flexibility in Rodents
- (2010) Vance L. Albaugh et al. SCHIZOPHRENIA BULLETIN
- Surrogate measures of insulin resistance: of rats, mice, and men
- (2009) Kieren Mather AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Roles of the Akt/GSK-3 and Wnt Signaling Pathways in Schizophrenia and Antipsychotic Drug Action
- (2009) Zachary Freyberg et al. AMERICAN JOURNAL OF PSYCHIATRY
- Antipsychotic-Induced Weight Gain in Chronic and First-Episode Psychotic Disorders
- (2009) Mario Álvarez-Jiménez et al. CNS DRUGS
- Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
- (2009) Bryan T. MacDonald et al. DEVELOPMENTAL CELL
- Metabolic syndrome and oxidative stress
- (2009) Katsuyuki Ando et al. FREE RADICAL BIOLOGY AND MEDICINE
- Visceral Obesity
- (2009) Patrick Mathieu et al. HYPERTENSION
- 30 Days of Continuous Olanzapine Infusion Determines Energy Imbalance, Glucose Intolerance, Insulin Resistance, and Dyslipidemia in Mice
- (2009) Roberto Coccurello et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Antipsychotic-induced oxidative stress in Rat Brain
- (2009) MÁrcio R. Martins et al. NEUROTOXICITY RESEARCH
- Genetic risk factors for type 2 diabetes with pharmacologic intervention in African-American patients with schizophrenia or schizoaffective disorder
- (2009) M.R. Irvin et al. SCHIZOPHRENIA RESEARCH
- Standards of Medical Care in Diabetes--2008: Response to Hirsch, Inzucchi, and Kirkman
- (2008) J. M. Dora et al. DIABETES CARE
- Minireview: The Wnt Signaling Pathway Effector TCF7L2 and Type 2 Diabetes Mellitus
- (2008) Tianru Jin et al. MOLECULAR ENDOCRINOLOGY
- Analyzing real-time PCR data by the comparative CT method
- (2008) Thomas D Schmittgen et al. Nature Protocols
- Differential Effects of Various Typical and Atypical Antipsychotics on Plasma Glucose and Insulin Levels in the Mouse: Evidence for the Involvement of Sympathetic Regulation
- (2008) Y. E. Savoy et al. SCHIZOPHRENIA BULLETIN
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search